Analgesic, probon, in the therapy of ischemic heart disease
Orlov, V.M.; Zadionchenko, V.S.; Romanenko, I.A.; Zvereva, T.V.
Klinicheskaia Meditsina 58(6): 35-38
1980
ISSN/ISBN: 0023-2149 PMID: 6893213 Document Number: 163063
Document emailed within 1 workday
Related Documents
Nagy, G. 1979: History of the development of Probon, a new minor analgesic Therapia Hungarica 27(1): 47-52Ihász, E. 1980: Analgesic effect of probon in acute and chronic locomotor diseases Therapia Hungarica 28(1): 22-27
Kuriata, A.V.; Karavanskaia, I.L.; Kushnir, I.S. 2011: The use of metabolic therapy in the treatment of ischemic heart disease in hemodynamically formed insignificant aortic stenosis with chronic heart failure Likars'ka Sprava 2011(7-8): 51-58
Eganian, R.A. 1986: Diet therapy in ischemic heart disease Meditsinskaia Sestra 45(3): 19-20
Dudchenko, M.A.; Rasin, M.S.; Kazakov, I.M.; Shkliar, A.S. 1984: Use of dibunol in the therapy of ischemic heart disease Klinicheskaia Meditsina 62(6): 77-79
Ueno, H. 1998: Angiogenic gene therapy for ischemic heart disease Nihon Rinsho. Japanese Journal of Clinical Medicine 56(10): 2645-2652
Fabián, J.; Bergmann, K. 1982: Pathophysiology, diagnosis and internal therapy of ischemic heart disease Casopis Lekaru Ceskych 121(31): 969-971
Vasil'ev, A.P.; Strel'tsova, N.N.; Senatorov, I.N. 2003: Efficacy of laser therapy in patients with ischemic heart disease Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 4: 10-13
Ostojić, M. 1993: Modern diagnosis and interventional therapy in ischemic heart disease Srpski Arhiv Za Celokupno Lekarstvo 121(1-2): 20-21
Kuch, J. 1986: Advances in studies on the etiopathogenesis and therapy of ischemic heart disease Polski Tygodnik Lekarski 41(41): 1299-1302
Kaem, G.R. 1975: Importance of long-term anticoagulant therapy in ischemic heart disease Terapevticheskii Arkhiv 47(10): 124-131
Ardashev, V.N.; Steklov, V.I. 1997: The programmed therapy of rhythm and conduction disorders in ischemic heart disease Voenno-Meditsinskii Zhurnal 318(7): 32-38
Meshcheriakova, V.A.; Iatsyshina, T.A.; Plotnikova, O.A.; Tsagikian, T.A.; Voĭtko, N.E. 1987: The role of soy protein in the diet therapy of patients with ischemic heart disease Voprosy Pitaniia 4: 16-21
Guliamov, K.G. 1974: Effect of anticoagulant therapy on vascular permeability in patients with ischemic heart disease Terapevticheskii Arkhiv 46(9): 75-80
Mikhin, V.P.; Kharchenko, A.V.; Sharova, V.G.; Cherniatina, M.A.; Mal'tseva, E.V. 2012: Efficacy of the use of coenzyme q10 at the background of traditional therapy of chronic ischemic heart disease Kardiologiia 52(10): 4-8
Kastrup, J.; Jørgensen, E. 2001: Gene therapy of ischemic heart disease. Growth factors and angiogenesis/arteriogenesis Ugeskrift for Laeger 163(1): 13-15
Salel, A.F.; Berman, D.S.; Mason, D.T. 1976: Nuclear cardiology in the evaluation of therapy and ventricular function in ischemic heart disease Heart and Lung: the Journal of Critical Care 5(4): 641-651
Belenkov, Y.N.; SHakaryants, G.A.; Khabarova, N.V. 2018: Tactics of Selection of Anticoagulant Therapy in Patients With Atrial Fibrillation and Ischemic Heart Disease Kardiologiia 2018(3): 43-52
Korochkin, I.M.; Kartelishev, A.V.; Kapustina, G.M.; Leshakov, S.I.; Berkinbaev, S.F. 1988: Clinico-pathogenetic aspects of the effectiveness of laser therapy in patients with ischemic heart disease Sovetskaia Meditsina 1: 23-27
Semenko, I.F. 1973: Indicators of the hemocoagulation system in patients with ischemic heart disease undergoing exercise therapy Terapevticheskii Arkhiv 45(6): 95-101